跳至主要内容
临床试验/NCT04558190
NCT04558190
已完成
不适用

Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle

University of Copenhagen1 个研究点 分布在 1 个国家目标入组 10 人2020年9月2日

概览

阶段
不适用
干预措施
Intralipid, 20% Intravenous Emulsion
疾病 / 适应症
Insulin Resistance
发起方
University of Copenhagen
入组人数
10
试验地点
1
主要终点
Whole body Insulin sensitivity
状态
已完成
最后更新
4年前

概览

简要总结

The purpose of the study is to evaluate the link between insulin resistance and alterations in skeletal muscle mitochondrial redox homeostasis

注册库
clinicaltrials.gov
开始日期
2020年9月2日
结束日期
2021年11月1日
最后更新
4年前
研究类型
Interventional
研究设计
Crossover
性别
Male

研究者

责任方
Principal Investigator
主要研究者

Morten Hostrup, PhD

Associate Professor

University of Copenhagen

入排标准

入选标准

  • Body mass index (BMI) ≥25 and \<40 kg/m2
  • Fasting plasma glucose ≥ 5.6 mmol/L or HbA1c ≥ 5.7%
  • HOMA2-IR \> 1.4
  • VO2max \<45 ml/kg/min

排除标准

  • Treatment with \>2 antidiabetic medications
  • Insulin usage
  • Chronic disease deemed by the study responsible medical doctor to interfere with any part of the study
  • Chronic use of prescription medicine deemed by the study responsible medical doctor to interfere with any part of the study

研究组 & 干预措施

Lipid infusion + MitoQ

Subjects undergo a hyperinsulinemic isoglycemic clamp preceded by MitoQ administration and intravenous lipid infusion

干预措施: Intralipid, 20% Intravenous Emulsion

Lipid infusion + MitoQ

Subjects undergo a hyperinsulinemic isoglycemic clamp preceded by MitoQ administration and intravenous lipid infusion

干预措施: MitoQ

Lipid infusion + placebo

Subjects undergo a hyperinsulinemic isoglycemic clamp preceded by placebo administration and intravenous lipid infusion

干预措施: Intralipid, 20% Intravenous Emulsion

Lipid infusion + beta2-agonist

Subjects undergo a hyperinsulinemic isoglycemic clamp with intravenous infusion of lipid and salbutamol

干预措施: Intralipid, 20% Intravenous Emulsion

Lipid infusion + beta2-agonist

Subjects undergo a hyperinsulinemic isoglycemic clamp with intravenous infusion of lipid and salbutamol

干预措施: Salbutamol

结局指标

主要结局

Whole body Insulin sensitivity

时间窗: 5 hours after lipid infusion

Whole body insulin sensitivity is determined by hyperinsulinemic isoglycemic clamp method

Skeletal muscle insulin sensitivity

时间窗: 5 hours after lipid infusion

Insulin-dependent skeletal muscle glucose uptake is determined by hyperinsulinemic isoglycemic clamp method integrated with measurements of femoral artery blood flow and arteriovenous difference of glucose

次要结局

  • Mitochondrial respiration(Baseline)
  • Mitochondrial reactive oxygen species(Baseline)
  • Mitochondrial oxidative stress(Before (baseline) as well as 3 and 5 hours after lipid infusion)
  • Muscle redox status(Before (baseline) as well as 3 and 5 hours after lipid infusion)
  • Insulin signalling(Before (baseline) as well as 3 and 5 hours after lipid infusion)

研究点 (1)

Loading locations...

相似试验